Seroprevalence of hepatitis B virus, hepatitis C virus and GB virus-C infections in Siberia
We studied the seroprevalence of hepatitis B virus (HBV), hepatitis C virus (HCV) and GB virus-C (GBV-C) infections in 348 Siberian natives who lived in the Kamchatka Peninsula of Russia. Of 348 samples studied, the seroprevalence of HBsAg and anti-HBs were 11·8% (41 of 348 samples) and 35·9% (125 o...
Gespeichert in:
| Veröffentlicht in: | Epidemiology and infection 1999-02, Vol.122 (1), p.139-144 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 144 |
|---|---|
| container_issue | 1 |
| container_start_page | 139 |
| container_title | Epidemiology and infection |
| container_volume | 122 |
| creator | OHBA, K. MIZOKAMI, M. KATO, T. UEDA, R. GURTSENVITCH, V. SENYUTA, N. SYRTSEV, A. ZOYA, K. YAMASHITA, M. HAYAMI, M. |
| description | We studied the seroprevalence of hepatitis B virus (HBV), hepatitis
C virus (HCV) and GB
virus-C (GBV-C) infections in 348 Siberian natives who lived in the Kamchatka
Peninsula of
Russia. Of 348 samples studied, the seroprevalence of HBsAg and anti-HBs
were 11·8% (41 of
348 samples) and 35·9% (125 of 348 samples), respectively. The prevalence
of HCV infection
was 1·4% (5 of 348 samples), and that of GBV-C RNA, using RT–PCR
methods, was 7·5%
(26 of 348 samples). In Siberia, the prevalences of HBV and GBV-C infections
were about
tenfold higher than those in Japan. The prevalence of HBsAg in subjects
under 50 years of age
was significantly higher than that in those over 50 years old (P |
| doi_str_mv | 10.1017/S0950268898001940 |
| format | Article |
| fullrecord | <record><control><sourceid>jstor_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2809599</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_S0950268898001940</cupid><jstor_id>3865246</jstor_id><sourcerecordid>3865246</sourcerecordid><originalsourceid>FETCH-LOGICAL-c529t-aedc545d1dbe2a3cb6caffdc22b1907144b155474aba40fe6eb1661b8d92e7223</originalsourceid><addsrcrecordid>eNqFkU-P0zAQxS0EYrsLHwAJoZw4EbAd_70gQVm6iEoIunCAg2Unk12XNC52UsG3x1WqqggJTh7N783TjB9Cjwh-TjCRL1ZYc0yFUlphTDTDd9CMMKFLxrC-i2Z7XO75GTpPaY0x1lTJ--iM5EpJLWfo2wpi2EbY2Q76GorQFrewtYMffCpeFzsfx_TspDWfWoXtm2Jx4OW88H0L9eBDn3JZrLyD6O0DdK-1XYKHh_cCfX57eT2_KpcfFu_mr5ZlzakeSgtNzRlvSOOA2qp2orZt29SUOqKxJIw5wjmTzDrLcAsCHBGCONVoCpLS6gK9nHy3o9tkM-iHaDuzjX5j4y8TrDd_kt7fmpuwM1TlH9I6Gzw9GMTwY4Q0mI1PNXSd7SGMyQgtuMCK_1dIJOWaib2QTMI6hpQitMdtCDb77Mxf2eWZJ6dnnExMYWXB40mwTkOIR14pwSkTGZcT9mmAn0ds43cjZCW5EYuP5uv18v2nq8Ub8yXrq8OOduOib27ArMMY-xzVP7b8DbDqvgM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17259465</pqid></control><display><type>article</type><title>Seroprevalence of hepatitis B virus, hepatitis C virus and GB virus-C infections in Siberia</title><source>Jstor Complete Legacy</source><source>MEDLINE</source><source>PubMed Central</source><creator>OHBA, K. ; MIZOKAMI, M. ; KATO, T. ; UEDA, R. ; GURTSENVITCH, V. ; SENYUTA, N. ; SYRTSEV, A. ; ZOYA, K. ; YAMASHITA, M. ; HAYAMI, M.</creator><creatorcontrib>OHBA, K. ; MIZOKAMI, M. ; KATO, T. ; UEDA, R. ; GURTSENVITCH, V. ; SENYUTA, N. ; SYRTSEV, A. ; ZOYA, K. ; YAMASHITA, M. ; HAYAMI, M.</creatorcontrib><description>We studied the seroprevalence of hepatitis B virus (HBV), hepatitis
C virus (HCV) and GB
virus-C (GBV-C) infections in 348 Siberian natives who lived in the Kamchatka
Peninsula of
Russia. Of 348 samples studied, the seroprevalence of HBsAg and anti-HBs
were 11·8% (41 of
348 samples) and 35·9% (125 of 348 samples), respectively. The prevalence
of HCV infection
was 1·4% (5 of 348 samples), and that of GBV-C RNA, using RT–PCR
methods, was 7·5%
(26 of 348 samples). In Siberia, the prevalences of HBV and GBV-C infections
were about
tenfold higher than those in Japan. The prevalence of HBsAg in subjects
under 50 years of age
was significantly higher than that in those over 50 years old (P<0·05).
Because HBV infection
is highly endemic in Siberia, we propose that the community-based mass
immunization must be
conducted as soon as possible in this area.</description><identifier>ISSN: 0950-2688</identifier><identifier>EISSN: 1469-4409</identifier><identifier>DOI: 10.1017/S0950268898001940</identifier><identifier>PMID: 10098797</identifier><language>eng</language><publisher>England: Cambridge University Press</publisher><subject>Adolescent ; Adult ; Age Distribution ; Aged ; Aged, 80 and over ; Endemic Diseases - prevention & control ; Endemic Diseases - statistics & numerical data ; Female ; Flaviviridae ; GB virus C ; Genotypes ; Hepacivirus ; Hepatitis antigens ; Hepatitis B - epidemiology ; Hepatitis B - immunology ; Hepatitis B - prevention & control ; Hepatitis B - virology ; Hepatitis B virus ; Hepatitis C - epidemiology ; Hepatitis C - immunology ; Hepatitis C - prevention & control ; Hepatitis C - virology ; Hepatitis C virus ; Hepatitis G virus ; Hepatitis, Viral, Human - epidemiology ; Hepatitis, Viral, Human - immunology ; Hepatitis, Viral, Human - prevention & control ; Hepatitis, Viral, Human - virology ; Humans ; Infections ; Male ; Middle Aged ; Population Surveillance ; Reverse Transcriptase Polymerase Chain Reaction ; RNA ; Seroepidemiologic Studies ; Serotyping ; Siberia - epidemiology ; Vaccination ; Viruses</subject><ispartof>Epidemiology and infection, 1999-02, Vol.122 (1), p.139-144</ispartof><rights>1999 Cambridge University Press</rights><rights>Copyright 1999 Cambridge University Press</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c529t-aedc545d1dbe2a3cb6caffdc22b1907144b155474aba40fe6eb1661b8d92e7223</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/3865246$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/3865246$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,723,776,780,799,881,27901,27902,53766,53768,57992,58225</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10098797$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>OHBA, K.</creatorcontrib><creatorcontrib>MIZOKAMI, M.</creatorcontrib><creatorcontrib>KATO, T.</creatorcontrib><creatorcontrib>UEDA, R.</creatorcontrib><creatorcontrib>GURTSENVITCH, V.</creatorcontrib><creatorcontrib>SENYUTA, N.</creatorcontrib><creatorcontrib>SYRTSEV, A.</creatorcontrib><creatorcontrib>ZOYA, K.</creatorcontrib><creatorcontrib>YAMASHITA, M.</creatorcontrib><creatorcontrib>HAYAMI, M.</creatorcontrib><title>Seroprevalence of hepatitis B virus, hepatitis C virus and GB virus-C infections in Siberia</title><title>Epidemiology and infection</title><addtitle>Epidemiol. Infect</addtitle><description>We studied the seroprevalence of hepatitis B virus (HBV), hepatitis
C virus (HCV) and GB
virus-C (GBV-C) infections in 348 Siberian natives who lived in the Kamchatka
Peninsula of
Russia. Of 348 samples studied, the seroprevalence of HBsAg and anti-HBs
were 11·8% (41 of
348 samples) and 35·9% (125 of 348 samples), respectively. The prevalence
of HCV infection
was 1·4% (5 of 348 samples), and that of GBV-C RNA, using RT–PCR
methods, was 7·5%
(26 of 348 samples). In Siberia, the prevalences of HBV and GBV-C infections
were about
tenfold higher than those in Japan. The prevalence of HBsAg in subjects
under 50 years of age
was significantly higher than that in those over 50 years old (P<0·05).
Because HBV infection
is highly endemic in Siberia, we propose that the community-based mass
immunization must be
conducted as soon as possible in this area.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age Distribution</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Endemic Diseases - prevention & control</subject><subject>Endemic Diseases - statistics & numerical data</subject><subject>Female</subject><subject>Flaviviridae</subject><subject>GB virus C</subject><subject>Genotypes</subject><subject>Hepacivirus</subject><subject>Hepatitis antigens</subject><subject>Hepatitis B - epidemiology</subject><subject>Hepatitis B - immunology</subject><subject>Hepatitis B - prevention & control</subject><subject>Hepatitis B - virology</subject><subject>Hepatitis B virus</subject><subject>Hepatitis C - epidemiology</subject><subject>Hepatitis C - immunology</subject><subject>Hepatitis C - prevention & control</subject><subject>Hepatitis C - virology</subject><subject>Hepatitis C virus</subject><subject>Hepatitis G virus</subject><subject>Hepatitis, Viral, Human - epidemiology</subject><subject>Hepatitis, Viral, Human - immunology</subject><subject>Hepatitis, Viral, Human - prevention & control</subject><subject>Hepatitis, Viral, Human - virology</subject><subject>Humans</subject><subject>Infections</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Population Surveillance</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>RNA</subject><subject>Seroepidemiologic Studies</subject><subject>Serotyping</subject><subject>Siberia - epidemiology</subject><subject>Vaccination</subject><subject>Viruses</subject><issn>0950-2688</issn><issn>1469-4409</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU-P0zAQxS0EYrsLHwAJoZw4EbAd_70gQVm6iEoIunCAg2Unk12XNC52UsG3x1WqqggJTh7N783TjB9Cjwh-TjCRL1ZYc0yFUlphTDTDd9CMMKFLxrC-i2Z7XO75GTpPaY0x1lTJ--iM5EpJLWfo2wpi2EbY2Q76GorQFrewtYMffCpeFzsfx_TspDWfWoXtm2Jx4OW88H0L9eBDn3JZrLyD6O0DdK-1XYKHh_cCfX57eT2_KpcfFu_mr5ZlzakeSgtNzRlvSOOA2qp2orZt29SUOqKxJIw5wjmTzDrLcAsCHBGCONVoCpLS6gK9nHy3o9tkM-iHaDuzjX5j4y8TrDd_kt7fmpuwM1TlH9I6Gzw9GMTwY4Q0mI1PNXSd7SGMyQgtuMCK_1dIJOWaib2QTMI6hpQitMdtCDb77Mxf2eWZJ6dnnExMYWXB40mwTkOIR14pwSkTGZcT9mmAn0ds43cjZCW5EYuP5uv18v2nq8Ub8yXrq8OOduOib27ArMMY-xzVP7b8DbDqvgM</recordid><startdate>199902</startdate><enddate>199902</enddate><creator>OHBA, K.</creator><creator>MIZOKAMI, M.</creator><creator>KATO, T.</creator><creator>UEDA, R.</creator><creator>GURTSENVITCH, V.</creator><creator>SENYUTA, N.</creator><creator>SYRTSEV, A.</creator><creator>ZOYA, K.</creator><creator>YAMASHITA, M.</creator><creator>HAYAMI, M.</creator><general>Cambridge University Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>199902</creationdate><title>Seroprevalence of hepatitis B virus, hepatitis C virus and GB virus-C infections in Siberia</title><author>OHBA, K. ; MIZOKAMI, M. ; KATO, T. ; UEDA, R. ; GURTSENVITCH, V. ; SENYUTA, N. ; SYRTSEV, A. ; ZOYA, K. ; YAMASHITA, M. ; HAYAMI, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c529t-aedc545d1dbe2a3cb6caffdc22b1907144b155474aba40fe6eb1661b8d92e7223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age Distribution</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Endemic Diseases - prevention & control</topic><topic>Endemic Diseases - statistics & numerical data</topic><topic>Female</topic><topic>Flaviviridae</topic><topic>GB virus C</topic><topic>Genotypes</topic><topic>Hepacivirus</topic><topic>Hepatitis antigens</topic><topic>Hepatitis B - epidemiology</topic><topic>Hepatitis B - immunology</topic><topic>Hepatitis B - prevention & control</topic><topic>Hepatitis B - virology</topic><topic>Hepatitis B virus</topic><topic>Hepatitis C - epidemiology</topic><topic>Hepatitis C - immunology</topic><topic>Hepatitis C - prevention & control</topic><topic>Hepatitis C - virology</topic><topic>Hepatitis C virus</topic><topic>Hepatitis G virus</topic><topic>Hepatitis, Viral, Human - epidemiology</topic><topic>Hepatitis, Viral, Human - immunology</topic><topic>Hepatitis, Viral, Human - prevention & control</topic><topic>Hepatitis, Viral, Human - virology</topic><topic>Humans</topic><topic>Infections</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Population Surveillance</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>RNA</topic><topic>Seroepidemiologic Studies</topic><topic>Serotyping</topic><topic>Siberia - epidemiology</topic><topic>Vaccination</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>OHBA, K.</creatorcontrib><creatorcontrib>MIZOKAMI, M.</creatorcontrib><creatorcontrib>KATO, T.</creatorcontrib><creatorcontrib>UEDA, R.</creatorcontrib><creatorcontrib>GURTSENVITCH, V.</creatorcontrib><creatorcontrib>SENYUTA, N.</creatorcontrib><creatorcontrib>SYRTSEV, A.</creatorcontrib><creatorcontrib>ZOYA, K.</creatorcontrib><creatorcontrib>YAMASHITA, M.</creatorcontrib><creatorcontrib>HAYAMI, M.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Epidemiology and infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>OHBA, K.</au><au>MIZOKAMI, M.</au><au>KATO, T.</au><au>UEDA, R.</au><au>GURTSENVITCH, V.</au><au>SENYUTA, N.</au><au>SYRTSEV, A.</au><au>ZOYA, K.</au><au>YAMASHITA, M.</au><au>HAYAMI, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Seroprevalence of hepatitis B virus, hepatitis C virus and GB virus-C infections in Siberia</atitle><jtitle>Epidemiology and infection</jtitle><addtitle>Epidemiol. Infect</addtitle><date>1999-02</date><risdate>1999</risdate><volume>122</volume><issue>1</issue><spage>139</spage><epage>144</epage><pages>139-144</pages><issn>0950-2688</issn><eissn>1469-4409</eissn><abstract>We studied the seroprevalence of hepatitis B virus (HBV), hepatitis
C virus (HCV) and GB
virus-C (GBV-C) infections in 348 Siberian natives who lived in the Kamchatka
Peninsula of
Russia. Of 348 samples studied, the seroprevalence of HBsAg and anti-HBs
were 11·8% (41 of
348 samples) and 35·9% (125 of 348 samples), respectively. The prevalence
of HCV infection
was 1·4% (5 of 348 samples), and that of GBV-C RNA, using RT–PCR
methods, was 7·5%
(26 of 348 samples). In Siberia, the prevalences of HBV and GBV-C infections
were about
tenfold higher than those in Japan. The prevalence of HBsAg in subjects
under 50 years of age
was significantly higher than that in those over 50 years old (P<0·05).
Because HBV infection
is highly endemic in Siberia, we propose that the community-based mass
immunization must be
conducted as soon as possible in this area.</abstract><cop>England</cop><pub>Cambridge University Press</pub><pmid>10098797</pmid><doi>10.1017/S0950268898001940</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0950-2688 |
| ispartof | Epidemiology and infection, 1999-02, Vol.122 (1), p.139-144 |
| issn | 0950-2688 1469-4409 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2809599 |
| source | Jstor Complete Legacy; MEDLINE; PubMed Central |
| subjects | Adolescent Adult Age Distribution Aged Aged, 80 and over Endemic Diseases - prevention & control Endemic Diseases - statistics & numerical data Female Flaviviridae GB virus C Genotypes Hepacivirus Hepatitis antigens Hepatitis B - epidemiology Hepatitis B - immunology Hepatitis B - prevention & control Hepatitis B - virology Hepatitis B virus Hepatitis C - epidemiology Hepatitis C - immunology Hepatitis C - prevention & control Hepatitis C - virology Hepatitis C virus Hepatitis G virus Hepatitis, Viral, Human - epidemiology Hepatitis, Viral, Human - immunology Hepatitis, Viral, Human - prevention & control Hepatitis, Viral, Human - virology Humans Infections Male Middle Aged Population Surveillance Reverse Transcriptase Polymerase Chain Reaction RNA Seroepidemiologic Studies Serotyping Siberia - epidemiology Vaccination Viruses |
| title | Seroprevalence of hepatitis B virus, hepatitis C virus and GB virus-C infections in Siberia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T21%3A21%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Seroprevalence%20of%20hepatitis%20B%20virus,%20hepatitis%20C%20virus%20and%20GB%20virus-C%20infections%20in%20Siberia&rft.jtitle=Epidemiology%20and%20infection&rft.au=OHBA,%20K.&rft.date=1999-02&rft.volume=122&rft.issue=1&rft.spage=139&rft.epage=144&rft.pages=139-144&rft.issn=0950-2688&rft.eissn=1469-4409&rft_id=info:doi/10.1017/S0950268898001940&rft_dat=%3Cjstor_pubme%3E3865246%3C/jstor_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17259465&rft_id=info:pmid/10098797&rft_cupid=10_1017_S0950268898001940&rft_jstor_id=3865246&rfr_iscdi=true |